The largest database of trusted experimental protocols

5 protocols using smooth muscle differentiation supplement

1

Culturing Human Cell Lines for Notch1 Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human embryonic kidney
(HEK) 293T cells stably expressing full-length Notch1 (HEK293 FLN1)
were cultured under puromycin selection (1 μg/mL) in complete
medium consisting of Dulbecco’s modified Eagle medium (Gibco)
supplemented with 5 vol % heat inactivated fetal bovine serum (Invitrogen)
and 1 vol % penicillin–streptomycin solution (Invitrogen),
at 37 °C and 5% CO2 in a humidified atmosphere. HEK293
FLN1 were seeded at a concentration of 1.0 × 105 cells/cm2.
Primary human coronary artery smooth muscle cells
(HCASMC, Lonza) were purchased at passage 3 and experiments were carried
out with cells at passage 5 or 6. Cells were cultured in 231 basal
medium (Gibco) supplemented with 5 vol % smooth muscle growth supplement
(SMGS, Gibco) and 1 vol % penicillin–streptomycin solution
(Invitrogen), at 37 °C and 5% CO2 in a humidified
incubator. As a control for the expression of α-smooth muscle
actin in the differentiated state, the basal medium was supplemented
with 1 vol % smooth muscle differentiation supplement (Gibco) instead
of SMGS. HCASMC was passaged at 80% confluency and seeded at a concentration
of 5 × 103 cells/cm2.
+ Open protocol
+ Expand
2

Culturing Contractile and Synthetic VSMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human coronary artery smooth muscle cells (Lonza) were cultured in Human Vascular Smooth Muscle Cell Basal Medium (Gibco) supplemented with 1% penicillin/streptomycin (Sigma-Aldrich) and either 5% Smooth Muscle Growth Supplement (SMGS, Gibco) to obtain synthetic VSMCs, or 1% Smooth Muscle Differentiation Supplement (SMDS, Gibco) for a minimum of 7 days to obtain contractile VSMCs. Cells were cultured in a humidified incubator at 37°C with 5% CO2, and media was refreshed every 2–3 days. Cells were passaged when 80%–90% confluent and used in experiments at passage 6 to 8.
+ Open protocol
+ Expand
3

Smooth Muscle and Cardiomyocyte Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
To evaluate the smooth muscle cell (SMC) differentiation ability, hCPCs were treated with Medium 231 (Gibco) supplemented with 5% FBS and smooth muscle differentiation supplement (Gibco) for 7 days. The medium was changed every 2 days. To investigate the cardiomyocyte differentiation ability, hCPCs were treated with MEM/EBSS medium (HyClone) supplemented with 2% FBS and 10 nM dexamethasone for 28 days. The medium was changed every day.
+ Open protocol
+ Expand
4

Differentiation of hCSCs into ECs, SMCs, and CMs

Check if the same lab product or an alternative is used in the 5 most similar protocols
To evaluate the ability of hCSCs to differentiate into ECs, hCSCs were cultured in a DMEM high glucose medium supplemented with 20% FBS, 1% P/S, and 30 ng/mL recombinant human basic fibroblast growth factor (R&D Systems) for 7 days. To differentiate hCSCs into smooth muscle cells (SMCs), hCSCs were cultured in Medium 231 supplemented with 5% FBS, 1% P/S, and 1× smooth muscle differentiation supplement (Gibco) for 7 days. The medium was changed every 2 days. To induce cellular differentiation into CM, hCSCs were cultured in a MEM/EBSS medium (HyClone) supplemented with 2% FBS, 1% P/S, and 10 nM dexamethasone (Sigma-Aldrich) for 28 days. The medium was changed every day. The ability of cells to differentiate was analyzed by qRT-PCR and immunofluorescence.
+ Open protocol
+ Expand
5

Smooth Muscle Cell Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
To measure the expression level of lncRNAs and their neighboring protein-coding genes during differentiation of smooth muscle cells, we cultured HCASM cells (Gibco) according to the manufacturer’s protocol. These cells were maintained in Medium 231 (Gibco) supplemented with Smooth Muscle Growth Supplement (Gibco), and harvested for the sample of synthetic phenotype. To obtain the sample of contractile or differentiated phenotype, HCASM cells stabilized in the growth media were cultured in Medium 231 supplemented with Smooth Muscle Differentiation Supplement (Gibco) for three days, and then collected. We used TRIzol Reagent (Invitrogen) to extract total RNA, performed reverse transcription using RevertAid Reverse Transcriptase (Thermo Scientific) with Random Hexamers (Invitrogen). Quantitative real time polymerase chain reaction (PCR) was performed using SYBR Green PCR Master Mix (Applied biosystems) in Rotor-Gene Q (Qiagen). The primer sequences for PCR were included in the supplementary table. The differentiation of these cells was confirmed by measuring the level of Calponin 1 (CNN1) and Smooth muscle protein 22-alpha (SM22α). For normalization, the expression level of Glyceraldehyde 3-phosphate dehydrogenase (GADPH) was used.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!